• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number HT084050J
Device Problems Patient-Device Incompatibility (2682); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Rupture (2208); Vascular Dissection (3160)
Event Date 11/15/2021
Event Type  Injury  
Event Description
The following information was reported to gore: on (b)(6) 2021, the patient underwent tevar with debranching for impending aortic rupture associated with stanford type b aortic dissection, and the propaten graft was used for axillo-axillary bypass.On (b)(6) 2021, the patient visited the hospital presenting a swelling of the graft implanted site which developed two weeks ago.On (b)(6) 2021, the patient was admitted to the hospital and aspiration of the seroma fluid was performed.The fluid was pale yellow (almost no color).Triglyceride of the fluid was low at 3 mg/dl and lymphatic leakage was unlikely.On (b)(6) 2021, the swelling was resolved.On an unknown date, aspiration of the seroma fluid was performed again.On (b)(6) 2021, since the patient condition was stable, an additional procedure was performed.The propaten graft was replaced with a new propaten graft.On an unknown date, the patient was discharged from the hospital.The device will be returned to gore for further investigation.
 
Manufacturer Narrative
¿other¿ was selected as device is still awaiting phr and evaluation.(b)(4).
 
Manufacturer Narrative
Added g3/g4, h1/h2, h6: investigation findings and conclusion.
 
Manufacturer Narrative
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® PROPATEN® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
samir kulovic
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key13011097
MDR Text Key283180450
Report Number2017233-2021-02613
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberHT084050J
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/06/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/19/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/28/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
Patient Weight49 KG
-
-